We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Endo Pharmaceuticals and Penwest Pharmaceuticals are suing Impax Laboratories for amending an ANDA to include the manufacture of generic 7.5-, 15- and 30-mg strengths of the pain drug Opana extended release (ER).